General Information of the Compound
| Compound ID |
CP0311689
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[4-[[2-(4-chlorophenyl)-6-[2-(dimethylamino)-2-oxoethoxy]phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C49H54ClF3N6O8S3
|
||||||||||||||||||
| Molecular Weight |
1043.653
|
||||||||||||||||||
| Canonical SMILES |
CN(C)C(=O)COc1cccc(c1CN1CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN2CCOCC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)-c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C49H54ClF3N6O8S3/c1-56(2)47(60)33-67-45-10-6-9-42(35-11-15-37(50)16-12-35)43(45)32-58-23-25-59(26-24-58)39-17-13-36(14-18-39)48(61)55-70(64,65)41-19-20-44(46(31-41)69(62,63)49(51,52)53)54-38(21-22-57-27-29-66-30-28-57)34-68-40-7-4-3-5-8-40/h3-20,31,38,54H,21-30,32-34H2,1-2H3,(H,55,61)/t38-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WKNCTFZEGFHUTO-KXQOOQHDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound